| Name | 2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethanol |
|---|---|
| Synonyms |
2-(4-Dibenzo[b,f][1,4]thiazin-11-yl-piperazin-1-yl)-ethanol
Desethoxy QuetiapineQ: What is Desethoxy Quetiapine Q: What is the CAS Number of Desethoxy Quetiapine Q: What is the storage condition of Desethoxy Quetiapine Q: What e the applications of Desethoxy Quetiapine quetiapine impurity I Quetiapine Impurity I/Quetiapine Hydroxy Impurit Pallel dimer Quetiapine fumate Imp. I : -(dibenzob,f1,4thiazin-11-yl)piperazin-1-ylethanol T C676 BS INJ C- AT6N DNTJ D2Q Quintiapine impurity I 2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethanol Quetiapine IMpurity I (Quetiapine Hydroxy IMpurity) Quetiapine Hydroxy Impurity Dihydrochloride Salt 2-(4-benzo[b][1,4]benzothiazin-6-ylpiperazin-1-yl)ethanol 2-(4-(dibenzo[b,f][1,4]thiazin-11-yl)piperazin-1-yl)ethanoldihydrochloride 1-Piperazineethanol, 4-dibenzo[b,f][1,4]thiazin-11-yl Quetiapine Impurity I (base)) QUETIAPINE DESETHOXY 2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol Quetiapine Impurity 2(Quetiapine Impurity I) O-Dealkyl Quetiapine QUETIAPINE DESETHOXY (1A00190) 4-Dibenzo[b,f][1,4]thiazin-11-yl-1-piperazineethanol Quetiapine Impurity I Control Quetiapine impurity 1 2-[4-(dibenzo[b,f][1,4]thiazin-11-yl)piperazin-1-yl]ethanol(Quetiapine Impurity I) Quetiapine Impurity 2 11-(4-[2-HYDROXYETHYL]PIPERAZIN-1-YL)DIBENZO[B,F][1,4]THIAZINE 11-[4-(2-Hydroxyethyl)-1-Piperazinyl]-Dibenzo[D, F][1,4]Thiazine 4-Dibenzo[β,f][1,4]thiazin-11-yl-1-piperazineethanol Quetiapine Deshydroxyethyl IMpurity Quetiapine Hydroxy Impurity |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 523.4±60.0 °C at 760 mmHg |
| Molecular Formula | C19H21N3OS |
| Molecular Weight | 339.454 |
| Flash Point | 270.3±32.9 °C |
| Exact Mass | 339.140533 |
| PSA | 64.37000 |
| LogP | 2.27 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.683 |
| Storage condition | 2-8°C |
|
~51%
329216-67-3 |
| Literature: CONCERT PHARMACEUTICALS INC. Patent: WO2008/66620 A2, 2008 ; Location in patent: Page/Page column 23-24 ; |
|
~83%
329216-67-3 |
| Literature: AUSPEX PHARMACEUTICALS, INC. Patent: US2010/69356 A1, 2010 ; Location in patent: Page/Page column 26-27 ; US 20100069356 A1 |
|
~92%
329216-67-3
Detail
|
| Literature: UNION QUIMICO-FARMACEUTICA S.A. Patent: WO2006/94549 A1, 2006 ; Location in patent: Page/Page column 17-18 ; |
|
~%
329216-67-3 |
| Literature: Warawa; Migler; Ohnmacht; Needles; Gatos; McLaren; Nelson; Kirkland Journal of Medicinal Chemistry, 2001 , vol. 44, # 3 p. 372 - 389 |